Skip to main content

Table 2 Effect of oral administration of whey proteins products on serum glucose and total cholesterol and on liver triglycerides of rats fed the normal and high carbohydrate, fat free diets

From: Protective effect of whey proteins against nonalcoholic fatty liver in rats

 

Blood glucose (mg/dL)

Total cholesterol (mg/dL)

TG (mg/g liver)

Control

86.69 ± 5.27d

71.92 ± 5.82ab

8.27 ± 1.08b

HCFFD

152.76 ± 20.81a

79.19 ± 9.85a

12.39 ± 2.32a

WPI

102.74 ± 10.96cd

69.29 ± 4.48ab

3.71 ± 1.64c

WPH

118.92 ± 10.61bc

63.74 ± 5.50ab

2.54 ± 0.31c

αLA

130.21 ± 16.95ab

51.72 ± 4.75b

3.07 ± 0.78c

βLG

115.06 ± 11.73bc

76.64 ± 7.47ab

2.58 ± 0.90c

GMP

95.02 ± 10.40cd

58.43 ± 6.55ab

2.59 ± 0.94c

  1. Mean values with their standard deviation for five rats per group
  2. WPI: whey protein isolate, WPH: whey protein hydrolysate, αLA: alpha lactalbumin, βLG: Beta lactoglobulin, GMP: glycomacropeptide, TG: triglyceride.
  3. Means in a column without common letter significantly differ, P < 0.05 (Tukey's test).